Keywords: merck, expands, eniporide, study, after, positive, data

Merck expands eniporide study after positive data

Article | 08 July 1999

Print This

Merck KGaA has announced that it will expand its Phase II trial ofeniporide, a novel sodium/proton exchange inhibitor designed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in